Form 4: Infleqtion Director Kristina Johnson Sells $853,500 in Stock

Director Kristina M. Johnson executed a series of transactions involving the sale of 50,000 shares and the exercise of low-cost stock options.

Summary

• Kristina M. Johnson, a Director at Infleqtion, Inc., sold a total of 50,000 shares of common stock on May 28, 2026.
• The transactions included the sale of 20,000 shares held indirectly through Catalyzer Ventures at a weighted average price of $18.00.
• Johnson exercised options for 30,000 shares at a strike price of $0.90 and immediately sold them at a weighted average price of $16.45.
• Following these transactions, Johnson's direct ownership of common stock is zero, while she retains 13,120 shares indirectly.
• The reporting person still holds 343,458 derivative securities in the form of stock options.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as neutral; while the liquidation is sizable, the director retains a very large position in unexercised options, maintaining alignment with the company's future performance.

Positives

• The director maintains a substantial long-term interest in the company through 343,458 remaining stock options.
• The exercise price of $0.90 relative to the market price of over $16.00 indicates significant historical value appreciation.
• Vesting of remaining options continues monthly, ensuring ongoing alignment with shareholder interests.

Negatives

• The director liquidated 50,000 shares in a single day, which may be interpreted by some investors as profit-taking at a perceived local peak.
• Direct ownership of common stock was reduced to zero following the exercise-and-sell transaction.
• The sale price for the exercised options ($16.45) was lower than the sale price for the indirect holdings ($18.00).

Risks

• Concentrated insider selling can occasionally precede periods of stock price consolidation or decline.
• The reliance on derivative securities (options) rather than direct share ownership may change the risk profile of the director's stake.

Future Outlook

The reporting person continues to vest options on a monthly basis (1/36th of the total grant), suggesting a multi-year horizon for the remaining 343,458 options subject to continued service.

Management Comments

• Dr. Johnson disclaims beneficial ownership of the securities held by Catalyzer Ventures, LP Fund I except to the extent of her pecuniary interest therein.

Industry Context

StockSavvy.ai notes that in high-growth technology sectors like quantum computing, it is common for directors to exercise deep-in-the-money options and liquidate portions of their holdings for personal financial planning and diversification.

Comparison to Industry Standards

• The use of a 36-month monthly vesting schedule is a standard corporate governance practice for director equity compensation.
• The weighted average price reporting for sales within a specific range is a standard SEC compliance procedure for high-volume insider trades.

Related Party Transactions

• The sale of 20,000 shares was executed by Catalyzer Ventures, LP Fund I, an entity where Dr. Johnson serves as a general partner.

Stakeholder Impact

• Shareholders may see increased trading volume and minor downward pressure from the sale of 50,000 shares in the open market.

Next Steps

• Continued monthly vesting of the remaining 343,458 stock options through the expiration date in 2034.

Key Dates

Recommendation

While insider selling can be a cautionary signal, the retention of over 340,000 options suggests the director remains committed to the company's long-term trajectory. Investors should wait to see if other insiders engage in similar liquidation patterns before changing their outlook.

Keywords

Infleqtion, INFQ, Insider Selling, Form 4, Stock Options, Kristina Johnson, Quantum Computing, Executive Compensation